Stockpiling drugs for an avian influenza outbreak: Examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic

Infection Control and Hospital Epidemiology

Volumn 30, Issue 4, 2009, Pages 370-376

  Gasink, Leanne B ^a   Linkin, Darren R ^a   Fishman, Neil O ^a   Bilker, Warren B ^a   Weiner, Mark G ^a   Lautenbach, Ebbing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADULT; AGED; ARTICLE; AVIAN INFLUENZA; CAUCASIAN; DRUG INDICATION; DRUG USE; EPIDEMIC; HEALTH SURVEY; HUMAN; INFORMATION CENTER; MAJOR CLINICAL STUDY; OUTPATIENT; PANDEMIC; PRESCRIPTION; QUESTIONNAIRE; RACE DIFFERENCE; UNITED STATES;

ADULT; AGED; ANIMALS; ANTIVIRAL AGENTS; BIRDS; CASE-CONTROL STUDIES; COMMUNICATIONS MEDIA; DISASTER PLANNING; DISEASE OUTBREAKS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MIDDLE AGED; OSELTAMIVIR; PRESCRIPTION DRUGS; QUESTIONNAIRES;

EID: 63449093584     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/596609     Document Type: Article

References (12)

1. Brett AS, Zuger A. The run on Tamiflu - should physicians prescribe on demand? New Engl J Med 2005; 353:2636-2637.
2. Ortiz JR, Kamimoto L, Aubert RE, Yao J, Epstein RS. Out-of-influenza- season oseltamivir prescriptions, 2004 and 2005. In: Program and abstracts of the 44th Annual meeting of the Infectious Diseases Society of America (IDSA). Arlington, VA; IDSA, 2006.
3. Ortiz JR, Shay DK, Liedtke LA, Bresee JS, Strausbaugh LJ. A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations. Clin Infect Dis 2006; 43:494-497.
4. M'ikanatha NM, Julian KG, Kunselman AR, Aber RC, Rankin JT, Lautenbach E. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak. BMC Public Health 2005; 5:2.
5. Brinker A, Pamer C, Beitz J. Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001. J Am Pharm Assoc 2003; 43:375-378.
6. Shaffer D, Armstrong G, Higgins K, et al. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial post-exposure prophylaxis campaign. Pharmacoepidemiol Drug Saf 2003; 12: 177-182.
7. Navas E. Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack. Clin Microbiol Infect 2002; 8:534-539.
8. Ceaser S, Wurtz R."Leftover" antibiotics in the medicine cabinet. Ann Intern Med 2000; 133:74.
9. Grigoryan L, Haaijer-Rysjamp FM, Burgerhof JG, et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 2006; 12:452-459
10. Richman PB, Garra G, Eskin B, Nashed AH, Cody R. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med 2001; 19:57-60.
11. World Health Organization. Avian influenza frequently asked questions. Available at: http://www.who.int/csr/disease/avian-influenza/avian-faqs/en/ index.html#drugs2. Accessed June 6, 2007.
12. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12:15-22.